REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase

Oncogene

Volumn 24, Issue 7, 2005, Pages 1138-1149

  Schwarzer, Rolf ^a   Tondera, Daniel ^a   Arnold, Wolfgang ^a   Giese, Klaus ^a   Klippel, Anke ^a   Kaufmann, Jörg ^a  

^a Atugen AG   (Germany)

Author keywords

Apoptosis; Gene silencing; Hypoxia; Phosphoinositide 3 kinase; Prostate cancer; RNA interference

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; HYPOXIA INDUCIBLE FACTOR 1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RAPAMYCIN;

APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENE LOSS; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; REDD1 GENE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; CELL HYPOXIA; CELL LINE, TUMOR; CHROMONES; COBALT; DIMETHYL SULFOXIDE; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MORPHOLINES; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; RNA, ANTISENSE; SIGNAL TRANSDUCTION; SIROLIMUS; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 14644395545     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208236     Document Type: Article

References (58)

1. Adler V, Yin Z, Tew KD and Ronai Z. (1999). Oncogene, 18, 6104-6111.
2. Akakura N, Kobayashi M, Horiuchi I, Suzuki A, Wang J, Chen J, Niizeki H, Kawamura K, Hosokawa M and Asaka M. (2001). Cancer Res., 61, 6548-6554.
3. Alvarez-Tejado M, Alfranca A, Aragones J, Vara A, Landazuri MO and del Peso L. (2002). J. Biol. Chem., 277, 13508-13517.
4. Anastasiadis AG, Bemis DL, Stisser BC, Salomon L, Ghafar MA and Buttyan R. (2003). Curr. Drug Targets, 4, 191-196.
5. Arsham AM, Plas DR, Thompson CB and Simon MC. (2002). J. Biol. Chem., 277, 15162-15170.
6. Arsham AM, Plas DR, Thompson CB and Simon MC. (2004). Cancer Res., 64, 3500-3507.
7. Baek JH, Jang JE, Kang CM, Chung HY, Kim ND and Kim KW. (2000). Oncogene, 19, 4621-4631.
8. Bardos JI, Chau NM and Ashcroft M. (2004). Mol. Cell. Biol., 24, 2905-2914.
9. Blouw B, Song H, Tihan T, Bosze J, Ferrara N, Gerber HP, Johnson RS and Bergers G. (2003). Cancer Cell, 4, 133-146.
10. Bottaro DP and Liotta LA. (2003). Nature, 423, 593-595.
11. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A and Fusenig NE. (1988). J. Cell Biol., 106, 761-771.
12. Cantley LC and Neel BG. (1999). Proc. Natl. Acad. Sci. USA, 96, 4240-4245.
13. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshert E and Keshet E. (1998). Nature, 394, 485-490.
14. Chrastina A. (2003). Neoplasma, 50, 251-256.
15. Chun YS, Choi E, Kim GT, Choi H, Kim CH, Lee MJ, Kim MS and Park JW. (2000). Eur. J. Biochem., 267, 4198-4204.
16. Coffer PJ, Jin J and Woodgett JR. (1998). Biochem. J., 335 (Part 1), 1-13.
17. Czauderna F, Fechtner M, Aygun H, Arnold W, Klippel A, Giese K and Kaufmann J. (2003a). Nucleic Acids Res., 31, 670-682.
18. Czauderna F, Santel A, Hinz M, Fechtner M, Durieux B, Fisch G, Leenders F, Arnold W, Giese K, Klippel A and Kaufmann J. (2003b). Nucleic Acids Res., 31, e127.
19. Di Cristofano A and Pandolfi PP. (2000). Cell, 100, 387-390.
20. Ellisen LW, Ramsayer KD, Johannessen CM, Yang A, Beppu H, Minda K, Oliner JD, McKeon F and Haber DA. (2002). Mol. Cell, 10, 995-1005.
21. Finkel T. (2000). FEBS Lett., 476, 52-54.
22. Ghafar MA, Anastasiadis AG, Chen MW, Burchardt M, Olsson LE, Xie H, Benson MC and Buttyan R. (2003). Prostate, 54, 58-67.
23. Hanahan D and Weinberg RA. (2000). Cell, 100, 57-70.
24. Harris AL. (2002). Nat. Rev. Cancer, 2, 38-47.
25. Hockel M and Vaupel P. (2001). Semin. Oncol., 28, 36-41.
26. Hudson CC, Liu M, Chiang GG, Otterness DM, Loomis DC, Kaper F, Giaccia AJ and Abraham RT. (2002). Mol. Cell. Biol., 22, 7004-7014.
27. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS and Kaelin Jr WG. (2001). Science, 292, 464-468.
28. Jiang BH, Jiang G, Zheng JZ, Lu Z, Hunter T and Vogt PK. (2001). Cell Growth Differ., 12, 363-369.
29. Kaufmann J, Pronk G, Giese K and Klippel A. (2004). Biochem. Soc. Trans., 32, 355-359.
30. Klippel A, Escobedo MA, Wachowicz MS, Apell G, Brown TW, Giedlin MA, Kavanaugh WM and Williams LT. (1998). Mol. Cell Biol., 18, 5699-5711.
31. Klippel A, Reinhard C, Kavanaugh WM, Apell G, Escobedo MA and Williams LT. (1996). Mol. Cell. Biol., 16, 4117-4127.
32. Kretschmer A, Moepert K, Dames S, Sternberger M, Kaufmann J and Klippel A. (2003). Oncogene, 22, 6748-6763.
33. Kulik G, Klippel A and Weber MJ. (1997). Mol. Cell. Biol., 17, 1595-1606.
34. Leenders F, Mopert K, Schmiedeknecht A, Santel A, Czauderna F, Aleku M, Penschuck S, Dames S, Sternberger M, Rohl T, Wellmann A, Arnold W, Giese K, Kaufmann J and Klippel A. (2004). EMBO J., 23, 3303-3313.
35. Mudgil AV, Segal N, Andriani F, Wang Y, Fusenig NE and Garlick JA. (2003). J. Invest. Dermatol., 121, 191-197.
36. Paul SA, Simons JW and Mabjeesh NJ. (2004). J. Cell Physiol., 200, 20-30.
37. Piret JP. Lecocq C, Toffoli S, Ninane N, Raes M and Michiels C. (2004). Exp. Cell Res., 295, 340-349.
38. Piret JP, Mottet D, Raes M and Michiels C. (2002a). Ann. N Y Acad. Sci., 973, 443-447.
39. Piret JP, Mottet D, Raes M and Michiels C. (2002b). Biochem. Pharmacol., 64, 889-892.
40. Poellinger L and Johnson RS. (2004). Curr. Opin. Genet. Dev., 14, 81-85.
41. Salnikow K, Su W, Blagosklonny MV and Costa M. (2000). Cancer Res., 60, 3375-3378.
42. Schmeichel KL and Bissell MJ. (2003). J. Cell. Sci., 116, 2377-2388.
43. Semenza G. (2002). Biochem. Pharmacol., 64, 993-998.
44. Semenza GL. (2003). Nat. Rev. Cancer, 3, 721-732.
45. Sheta EA, Trout H, Gildea JJ, Harding MA and Theodorescu D. (2001). Oncogene, 20, 7624-7634.
46. Shoshani T, Faerman A, Mett I, Zelin E, Tenne T, Gorodin S, Moshel Y, Elbaz S, Budanov A, Chajut A, Kalinski H, Kamer I, Rozen A, Mor O, Keshet E, Leshkowitz D, Einat P, Skaliter R and Feinstein E. (2002). Mol. Cell. Biol., 22, 2283-2293.
47. Simpson L and Parsons R. (2001). Exp. Cell Res., 264, 29-41.
48. Soldani C and Scovassi AI. (2002). Apoptosis, 7, 321-328.
49. Stephenson RA, Dinney CP, Gohji K, Ordonez NG, Killion JJ and Fidler IJ. (1992). J. Natl. Cancer Inst., 84, 951-957.
50. Sternberger M, Schmiedeknecht A, Kretschmer A, Gebhardt F, Leenders F, Czauderna F, Von Carlowitz I, Engle M, Giese K, Beigelman L and Klippel A. (2002). Antisense Nucleic Acid Drug Dev., 12, 131-143.
51. Tondera D, Santel A, Schwarzer R, Dames S, Giese K, Klippel A and Kaufmann J. (2004). J. Biol. Chem., 279, 31544-31555.
52. Vanhaesebroeck B and Waterfield MD. (1999). Exp. Cell Res., 253, 239-254.
53. Vazquez F and Sellers WR. (2000). Biochim. Biophys. Acta, 1470, M21-M35.
54. Yim S, Choi SM, Choi Y, Lee N, Chung J and Park H. (2003). J. Biol. Chem., 278, 38260-38268.
55. Zaman K, Ryu H, Hall D, O'Donovan K, Lin KI, Miller MP, Marquis JC, Baraban JM, Semenza GL and Ratan RR. (1999). J. Neurosci., 19, 9821-9830.
56. Zhang SX, Gozal D, Sachleben Jr LR, Rane M, Klein JB and Gozal E. (2003). FASEB J., 17, 1709-1711.
57. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons JW. (1999). Cancer Res., 59, 5830-5835.
58. Zhou J, Schmid T, Frank R and Brune B. (2004). J. Biol. Chem., 279, 13506-13513.